Joji Toyota

Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection

Hiromitsu Kumada, Yoshiyuki Suzuki, Kenji Ikeda et al. · Hepatology · 2014 · 538 citations · Full text

Dual therapy with the nonstructural protein 5A inhibitor, daclatasvir, and the nonstructural protein 3 protease inhibitor, asunaprevir, in hepatitis C virus genotype 1b–infected null responders

Kazuaki Chayama, Shoichi Takahashi, Joji Toyota et al. · Hepatology · 2011 · 335 citations

Telaprevir with peginterferon and ribavirin for treatment-naive patients chronically infected with HCV of genotype 1 in Japan

Hiromitsu Kumada, Joji Toyota, Takeshi Okanoue et al. · Journal of Hepatology · 2011 · 252 citations

Viral Persistence, Hepatitis C, Viral Hepatitis +9

Dual oral therapy with daclatasvir and asunaprevir for patients with HCV genotype 1b infection and limited treatment options

Yoshiyuki Suzuki, Kenji Ikeda, Fumitaka Suzuki et al. · Journal of Hepatology · 2012 · 235 citations

Limited Treatment Options, Viral Hepatitis, Hcv Genotype 1B +9

Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma

Norikazu Iwata, Hiroyuki Yamamoto, Shigeru Sasaki et al. · Oncogene · 2000 · 229 citations

Epigenetic Regulation, Medicine, Natural Sciences +11